Sort
30,917 grants matching “tumor microenvironment”
Cancer Stem Cells in Cholangiocarcinoma
$431,712Changqing Xie · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Differences in Tumor Biology of Multiple Myeloma in Association with African Ancestry
$431,708Linda B Baughn · Mayo Clinic Rochester · R37 · FY2023 · CA
Exploiting the immunomodulatory effects of sulindac and novel non-COX inhibitory derivatives for cancer treatment
$431,691Gang Zhou · Augusta University · R01 · FY2021 · CA
Targeting pancreatic cancer's metabolic addiction to HuR
$431,688Jordan M Winter · Case Western Reserve University · R37 · FY2023 · CA
Clinical and pre-clinical investigation of extracellular vesicles as a mechanism of toxicity in the bladder of prostate cancer patients treated with radiotherapy
$431,650Yi-Fen Lee · University Of Rochester · R01 · FY2025 · CA
Local and systemic control of multiple myeloma colonization and growth by MMP-13
$431,631Conor C Lynch · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Local and systemic control of multiple myeloma colonization and growth by MMP-13
$431,630Conor C Lynch · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Biobehavioral pathways linking stress and cancer progression
$431,577Jennifer L. Steel · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · CA
Probing cellular, molecular and biomechanical barriers to immunotherapy in the tumor microenvironment with organotypic in vitro models of the tumor-lympho-immune interface
$431,440Melody A Swartz · University Of Chicago · R01 · FY2023 · CA
Probing cellular, molecular and biomechanical barriers to immunotherapy in the tumor microenvironment with organotypic in vitro models of the tumor-lympho-immune interface
$431,440Melody A Swartz · University Of Chicago · R01 · FY2022 · CA
Improving genetically engineered T cells for medulloblastomas
$431,432Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2024 · NS
Immune activation by necroptotic cell death
$431,384Andrew Atwell Oberst · University Of Washington · R01 · FY2020 · CA
Mechanisms Used by NKT Cells in the Control of Liver Tumors
$431,351Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Characterization of the interaction between inflammation and cancer progression
$431,351Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Immune Checkpoints and HPV-associated Head and Neck Cancers
$431,300Sara Isabel Pai · Massachusetts General Hospital · R01 · FY2016 · DE
Immune Checkpoints and HPV-associated Head and Neck Cancers
$431,300Sara Isabel Pai · Massachusetts General Hospital · R01 · FY2015 · DE
Exosome secretion in breast cancer progression
$431,289Alissa M Weaver · Vanderbilt University · R01 · FY2024 · CA
The study of neuro-vascular interaction in the central nervous system
$431,243Yosuke Mukoyama · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Targeting LKB1-null lung adenocarcinoma with innate immune system
$431,156Wei Zhou · Emory University · R01 · FY2023 · CA
Discovery of novel PCFT-targeted agents
$431,131Larry H. Matherly · Wayne State University · R01 · FY2013 · CA
Collagen structural changes as an early biomarker for breast carcinoma
$431,130Matthew W Conklin · University Of Wisconsin-Madison · R01 · FY2017 · CA
Mechanisms of immunotherapy response and resistance in pancreatic ductal adenocarcinoma
$431,094Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2021 · CA
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease
$431,066Matthew J. Flick · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · CA
Gene Function, Expression and Regulation in Zebrafish
$431,031Benjamin Feldman · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIC · FY2015 · HD
Role of microbial-modulated bile acid receptor signaling in breast cancer
$431,028Liza Makowski Hayes · University Of Tennessee Health Sci Ctr · R01 · FY2022 · CA